EUVIMEDEUVIMED entdecken
Crossref

Iguratimod Alleviates Experimental Sjögren’s Syndrome by Inhibiting NLRP3 Inflammasome Activation

Qi Zhang, Xi-Rui Yang, Yao Deng

Cell Biochemistry and Biophysics · 2024-09 · 82 (3) · 2275-2283

DOI: 10.1007/s12013-024-01337-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, online erschienen am 05.06.2024. Verfasst von Qi Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Shengli Oilfield Central Hospital, Dongying, Shandong, 257034, China. Hauptthemen laut MEDLINE: Sjogren's Syndrome, NLR Family, Pyrin Domain-Containing 3 Protein, Submandibular Gland, Inflammasomes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sjogren's SyndromeNLR Family, Pyrin Domain-Containing 3 ProteinSubmandibular GlandInflammasomesApoptosisDisease Models, AnimalSulfonamidesAnimalsMiceHumansChromonesFemaleCytokinesMice, Inbred C57BL

Stichwörter der Autor:innen

IguratimodNLRP3 inflammasomeSjögren’s syndrome

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesiguratimodSulfonamidesChromonesCytokinesNlrp3 protein, mouse

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, Shengli Oilfield Central Hospital, Dongying, Shandong, 257034, China.
  • Department of Rheumatology and Immunology, Shengli Oilfield Central Hospital, Dongying, Shandong, 257034, China. dydengyao@126.com.

Zitieren

APA

Zhang, Q., Yang, X. R., & Deng, Y. (2024). Iguratimod Alleviates Experimental Sjögren’s Syndrome by Inhibiting NLRP3 Inflammasome Activation. Cell Biochemistry and Biophysics, 82(3), 2275-2283. https://doi.org/10.1007/s12013-024-01337-2

Vancouver

Zhang Q, Yang XR, Deng Y. Iguratimod Alleviates Experimental Sjögren’s Syndrome by Inhibiting NLRP3 Inflammasome Activation. Cell Biochemistry and Biophysics. 2024;82(3):2275-2283. doi:10.1007/s12013-024-01337-2

BibTeX
@article{Zhang2024,
  author = {Zhang, Qi and Yang, Xi-Rui and Deng, Yao},
  title = {Iguratimod Alleviates Experimental Sjögren’s Syndrome by Inhibiting NLRP3 Inflammasome Activation},
  journal = {Cell Biochemistry and Biophysics},
  year = {2024},
  volume = {82},
  number = {3},
  pages = {2275--2283},
  doi = {10.1007/s12013-024-01337-2}
}
Kostenlos starten →